Search CommunityWalk:



400 North Broadway
Baltimore, MD 21287, US

Category: Drug Delivery

Used in the following map:

Maryland Biotech Industry Map

User Rating

GrayBug™ is a platform drug delivery company that is developing proprietary controlled release technologies for ophthalmic pharmaceutical indications. The company’s lead product is a polymer-drug biomolecular conjugate for the treatment of neovascular diseases, including age-related macular degeneration (AMD). GrayBug also has a proprietary platform technology that allows sustained drug delivery into various compartments of the eye while minimizing inflammation common with current controlled release technologies applied to the eye.
These technologies were co-developed by the lead founder of Graybug, Justin Hanes, PhD, who is the Lewis J. Ort Professor of Ophthalmology at Johns Hopkins University with joint appointments in four other Hopkins departments including Biomedical Engineering, in collaboration with top ophthalmology clinician-scientists from the Wilmer Eye Institute, Dr. Peter Campochiaro and Dr. Peter J. McDonnell.